q-bio.GNNov 19, 2026

An Explainable and Scalable Hierarchical Tensor Framework for Integrating Multi-Omics and Digital Pathomics

Authors: Ahmad Hussein, Ali Anaissi, Mukesh Prasad, Ali Braytee

Organizations: School of Computer Science, University of Technology Sydney, Sydney, NSW, Australia. · TD School, University of Technology Sydney, Sydney, NSW, Australia. · School of Computer Science, The University of Sydney, Sydney, NSW, Australia.

Abstract

Background: Precision oncology requires integration of heterogeneous molecular and pathology data, yet many fusion models offer limited biologically grounded interpretability and struggle with missing modalities. Methods: We present Hierarchical Interpretable Tensor Fusion (HIT-Fuse), integrating six modalities: somatic copy number variation, DNA methylation, RNA sequencing, microRNA expression, RPPA protein abundance, and vision transformer-derived pathomics across four TCGA cohorts (glioma, lung adenocarcinoma, breast, and kidney cancer). Modality-specific autoencoders compress high-dimensional inputs, followed by two-stage CP tensor decomposition. Missing latent modalities are reconstructed using clinical covariates and observed omics to expand cohorts and retrain downstream models. A mathematical traceback mechanism enables global and local xAI attributions. Results: HIT-Fuse identifies distinct latent subgroups with significant survival stratification in glioma, breast, and kidney cohorts, both with complete and reconstructed modalities. Cohort expansion yields cohort-specific gains, including a 56.4% relative increase in weighted F1 for glioma. Biological validation against DepMap CRISPR screens, miRTarBase and RPPA annotations supports decoded drivers across all four cohorts. Essential gene rates range from 6.2% in glioma to 7.6% in lung cancer; example drivers include ANAPC11, SNRPD1, PLK1 and RPL14. Of decoded miRNAs, 71-92% have miRTarBase regulatory support, while 77-84% of selected genes are covered in DepMap. Conclusions: HIT-Fuse combines hierarchical tensor fusion, missing-modality reconstruction and traceable attributions to support interpretable multi-omics and digital pathology-based cancer prognosis across heterogeneous cohorts.

Figures & tables

Explore similar work

CardsList
  1. ProtoPathway: Biologically Structured Prototype-Pathway Fusion for Multimodal Cancer Survival Prediction

    May 20, 2026Amaya Gallagher-Syed, Costantino Pitzalis, Myles J. Lewis +2Cancer Survival PredictionOncology

  2. PathMoG: A Pathway-Centric Modular Graph Neural Network for Multi-Omics Survival Prediction

    Apr 27, 2026Di Wang, Chupei Tang, Junxiao Kong +3Survival AnalysisGraph Neural Networks

  3. Heterogeneous Graph Attention Network With Multimodal Feature Selection for Cancer Multiomics Integration

    Aug 5, 2024Sina Tabakhi, Charlotte Vandermeulen, Ian Sudbery +1Multi-Omics Data IntegrationHeterogeneous GNNs